Hot Features
プレミアム
登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Dr. Stephen A. SherwinIndependent Director | -25.00k | 2.53M | Derivative Exercise and Sale | 53.64 - 167.31 | 15.86k | - |
| 2026-06-05 | Dr. Jude OnyiaChief Scientific Officer | -2.44k | 0.00 | Other Disposition | - | 23.41k | -9.44% |
| 2026-06-04 | Ms. Leslie V. NorwalkIndependent Director | -1.25k | 210.07k | Automatic Disposition | 168.06 | 2.84k | -30.58% |
| 2026-06-02 | Ms. Julie S. CookeChief HR Officer | -11.97k | 1.89M | Automatic Disposition | 157.62 - 158.59 | 22.37k | -34.86% |
| 2026-06-02 | Ms. Julie S. CookeChief HR Officer | -24.97k | 1.85M | Derivative Exercise and Sale | 81.49 - 157.62 | 22.37k | - |
| 2026-06-02 | Dr. Sanjay KeswaniChief Medical Officer | 1.48k | 0.00 | Derivative Exercise and Retained Stock | - | 1.48k | - |
| 2026-06-02 | Dr. Sanjay KeswaniChief Medical Officer | -1.73k | 268.34k | Derivative Exercise and Sale | 154.84 | 1.48k | - |
| 2026-06-01 | Dr. Jude OnyiaChief Scientific Officer | -11.00k | 830.57k | Derivative Exercise and Sale | 84.74 - 160.25 | 25.85k | - |
| 2026-05-29 | Dr. Ingrid DelaetChief Regulatory Officer | -2.26k | 175.66k | Derivative Exercise and Sale | 79.02 - 156.71 | 16.23k | - |
| 2026-05-27 | Dr. Jude OnyiaChief Scientific Officer | -11.00k | 778.73k | Derivative Exercise and Sale | 84.74 - 155.53 | 25.85k | - |
| 2026-05-26 | Mr. David Warren BoyerChief Corporate Affairs Officer | -3.89k | 609.02k | Automatic Disposition | 156.64 | 7.80k | -33.27% |
| 2026-05-21 | Dr. Stephen A. SherwinIndependent Director | 3.32k | 0.00 | Derivative Exercise and Retained Stock | - | 15.86k | 26.46% |
| 2026-05-21 | Dr. William H. RastetterIndependent Chairman of the Board | 3.32k | 0.00 | Derivative Exercise and Retained Stock | - | 43.68k | 8.22% |
| 2026-05-21 | Ms. Shalini SharpIndependent Director | 1.66k | 0.00 | Derivative Exercise and Retained Stock | - | 4.09k | 68.30% |
| 2026-05-21 | Mr. Richard F. PopsIndependent Director | 3.32k | 0.00 | Derivative Exercise and Retained Stock | - | 37.80k | 9.62% |
| 2026-05-21 | Ms. Christine Ann PoonIndependent Director | 3.32k | 0.00 | Derivative Exercise and Retained Stock | - | 4.75k | 231.22% |
| 2026-05-21 | Mr. George J. MorrowIndependent Director | 3.32k | 0.00 | Derivative Exercise and Retained Stock | - | 10.39k | 46.94% |
| 2026-05-21 | Ms. Leslie V. NorwalkIndependent Director | 1.66k | 0.00 | Derivative Exercise and Retained Stock | - | 4.09k | 68.30% |
| 2026-05-21 | Mr. Gary A. LyonsIndependent Director | 1.66k | 0.00 | Derivative Exercise and Retained Stock | - | 122.14k | 1.38% |
| 2026-05-21 | Ms. Johanna MercierIndependent Director | 3.32k | 0.00 | Derivative Exercise and Retained Stock | - | 6.85k | 93.86% |
| 2026-05-19 | Dr. Kevin C. GormanDirector | -205.09k | 22.78M | Derivative Exercise and Sale | 43.24 - 154.33 | 511.29k | - |
| 2026-05-19 | Dr. Kevin C. GormanDirector | -40.00k | 6.17M | Automatic Disposition | 154.33 | 511.29k | -7.26% |
| 2026-05-15 | Mr. Richard F. PopsIndependent Director | -15.00k | 1.65M | Derivative Exercise and Sale | 47.89 - 157.65 | 34.48k | - |
| 2026-05-12 | Ms. Leslie V. NorwalkIndependent Director | -3.81k | 590.60k | Automatic Disposition | 155.01 | 2.43k | -61.07% |
| 2026-03-04 | Mr. Matthew C. AbernethyCFO | -2.25k | 0.00 | Other Disposition | - | 42.81k | -4.99% |
| 2026-02-20 | Dr. Jude OnyiaChief Scientific Officer | -3.11k | 0.00 | Other Disposition | - | 25.67k | -10.81% |
| 2026-02-12 | Mr. David Warren BoyerChief Corporate Affairs Officer | 2.28k | 0.00 | Derivative Exercise and Retained Stock | - | 11.58k | 24.49% |
| 2026-02-12 | Mr. David Warren BoyerChief Corporate Affairs Officer | -2.67k | 331.02k | Derivative Exercise and Sale | 123.10 - 124.12 | 11.58k | - |
| 2026-02-13 | Mr. David Warren BoyerChief Corporate Affairs Officer | -5.38k | 667.52k | Sale to Issuer | 124.12 | 11.58k | -31.71% |
| 2026-02-12 | Mr. Matthew C. AbernethyCFO | 3.19k | 0.00 | Derivative Exercise and Retained Stock | - | 44.88k | 7.66% |
| 2026-02-12 | Mr. Matthew C. AbernethyCFO | -3.75k | 463.78k | Derivative Exercise and Sale | 123.10 - 124.12 | 44.88k | - |
| 2026-02-13 | Mr. Matthew C. AbernethyCFO | -5.38k | 667.52k | Sale to Issuer | 124.12 | 44.88k | -10.70% |
| 2026-02-12 | Mr. Kyle W. GanoPresident, CEO & Director | 4.47k | 0.00 | Derivative Exercise and Retained Stock | - | 150.82k | 3.06% |
| 2026-02-12 | Mr. Kyle W. GanoPresident, CEO & Director | -5.24k | 648.06k | Derivative Exercise and Sale | 123.10 - 124.12 | 150.82k | - |
| 2026-02-13 | Mr. Kyle W. GanoPresident, CEO & Director | -5.38k | 667.52k | Sale to Issuer | 124.12 | 150.82k | -3.44% |
| 2026-02-12 | Mr. Eric S. BenevichChief Commercial Officer | 2.79k | 0.00 | Derivative Exercise and Retained Stock | - | 63.19k | 4.61% |
| 2026-02-12 | Mr. Eric S. BenevichChief Commercial Officer | -3.26k | 404.02k | Derivative Exercise and Sale | 123.10 - 124.12 | 63.19k | - |
| 2026-02-13 | Mr. Eric S. BenevichChief Commercial Officer | -8.96k | 1.11M | Sale to Issuer | 124.12 | 63.19k | -12.42% |
| 2026-02-12 | Dr. Jude OnyiaChief Scientific Officer | 3.62k | 0.00 | Derivative Exercise and Retained Stock | - | 28.78k | 14.40% |
| 2026-02-12 | Dr. Jude OnyiaChief Scientific Officer | -4.34k | 537.72k | Derivative Exercise and Sale | 123.10 - 124.12 | 28.78k | - |
| 2026-02-13 | Dr. Jude OnyiaChief Scientific Officer | -10.76k | 1.33M | Sale to Issuer | 124.12 | 28.78k | -27.20% |
| 2026-02-12 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | 2.71k | 0.00 | Derivative Exercise and Retained Stock | - | 54.73k | 5.21% |
| 2026-02-12 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | -3.18k | 393.72k | Derivative Exercise and Sale | 123.10 - 124.12 | 54.73k | - |
| 2026-02-13 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | -5.38k | 667.52k | Sale to Issuer | 124.12 | 54.73k | -8.95% |
| 2026-02-13 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | -365.00 | 0.00 | Other Disposition | - | 54.73k | -0.66% |
| 2026-02-12 | Ms. Julie S. CookeChief HR Officer | 1.98k | 0.00 | Derivative Exercise and Retained Stock | - | 34.17k | 6.14% |
| 2026-02-12 | Ms. Julie S. CookeChief HR Officer | -2.32k | 287.19k | Derivative Exercise and Sale | 123.10 - 124.12 | 34.17k | - |
| 2026-02-13 | Ms. Julie S. CookeChief HR Officer | -5.38k | 667.52k | Sale to Issuer | 124.12 | 34.17k | -13.60% |
| 2026-02-13 | Dr. Kevin C. GormanDirector | 5.06k | 0.00 | Derivative Exercise and Retained Stock | - | 551.29k | 0.93% |
| 2026-02-13 | Dr. Kevin C. GormanDirector | -5.93k | 735.41k | Derivative Exercise and Sale | 124.12 | 551.29k | - |
| 2026-02-13 | Dr. Kevin C. GormanDirector | -34.38k | 4.27M | Sale to Issuer | 124.12 | 551.29k | -5.87% |
| 2026-02-12 | Dr. Ingrid DelaetChief Regulatory Officer | 1.99k | 0.00 | Derivative Exercise and Retained Stock | - | 16.23k | 13.97% |
| 2026-02-12 | Dr. Ingrid DelaetChief Regulatory Officer | -2.37k | 293.39k | Derivative Exercise and Sale | 123.10 - 124.12 | 16.23k | - |
| 2026-02-13 | Dr. Ingrid DelaetChief Regulatory Officer | -10.76k | 1.33M | Sale to Issuer | 124.12 | 16.23k | -39.86% |
| 2026-01-31 | Mr. David Warren BoyerChief Corporate Affairs Officer | 907.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.71k | 23.83% |
| 2026-01-31 | Mr. David Warren BoyerChief Corporate Affairs Officer | -1.19k | 161.78k | Derivative Exercise and Sale | 136.06 | 4.71k | - |
| 2026-01-31 | Mr. Eric S. BenevichChief Commercial Officer | 1.00k | 0.00 | Derivative Exercise and Retained Stock | - | 52.76k | 1.94% |
| 2026-01-31 | Mr. Eric S. BenevichChief Commercial Officer | -1.29k | 175.79k | Derivative Exercise and Sale | 136.06 | 52.76k | - |
| 2026-01-31 | Mr. Matthew C. AbernethyCFO | 1.07k | 0.00 | Derivative Exercise and Retained Stock | - | 37.10k | 2.97% |
| 2026-01-31 | Mr. Matthew C. AbernethyCFO | -1.37k | 186.13k | Derivative Exercise and Sale | 136.06 | 37.10k | - |
| 2026-01-31 | Ms. Julie S. CookeChief HR Officer | 744.00 | 0.00 | Derivative Exercise and Retained Stock | - | 27.60k | 2.77% |
| 2026-01-31 | Ms. Julie S. CookeChief HR Officer | -997.00 | 135.65k | Derivative Exercise and Sale | 136.06 | 27.60k | - |
| 2026-01-31 | Dr. Ingrid DelaetChief Regulatory Officer | 326.00 | 0.00 | Derivative Exercise and Retained Stock | - | 5.06k | 6.89% |
| 2026-01-31 | Dr. Ingrid DelaetChief Regulatory Officer | -475.00 | 64.63k | Derivative Exercise and Sale | 136.06 | 5.06k | - |
| 2026-01-31 | Mr. Kyle W. GanoPresident, CEO & Director | 1.35k | 0.00 | Derivative Exercise and Retained Stock | - | 141.75k | 0.96% |
| 2026-01-31 | Mr. Kyle W. GanoPresident, CEO & Director | -1.58k | 214.97k | Derivative Exercise and Sale | 136.06 | 141.75k | - |
| 2026-01-31 | Dr. Kevin C. GormanDirector | 2.30k | 0.00 | Derivative Exercise and Retained Stock | - | 516.89k | 0.45% |
| 2026-01-31 | Dr. Kevin C. GormanDirector | -2.85k | 387.09k | Derivative Exercise and Sale | 136.06 | 516.89k | - |
| 2026-01-31 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | 1.04k | 0.00 | Derivative Exercise and Retained Stock | - | 47.79k | 2.22% |
| 2026-01-31 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | -1.34k | 181.64k | Derivative Exercise and Sale | 136.06 | 47.79k | - |
| 2026-01-31 | Dr. Jude OnyiaChief Scientific Officer | 96.00 | 0.00 | Derivative Exercise and Retained Stock | - | 15.98k | 0.60% |
| 2026-01-31 | Dr. Jude OnyiaChief Scientific Officer | -142.00 | 19.32k | Derivative Exercise and Sale | 136.06 | 15.98k | - |
| 2026-01-16 | Mr. Kyle W. GanoPresident, CEO & Director | -36.40k | 3.52M | Derivative Exercise and Sale | 35.99 - 132.71 | 140.41k | - |
| 2025-11-28 | Mr. Eric S. BenevichChief Commercial Officer | 12.83k | 461.75k | Derivative Exercise and Retained Stock | 35.99 | 51.75k | 32.96% |
| 2026-01-08 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | 3.35k | 120.53k | Derivative Exercise and Retained Stock | 35.99 | 46.75k | 7.72% |
| 2025-12-15 | Ms. Leslie V. NorwalkIndependent Director | 3.81k | 351.85k | Derivative Exercise and Retained Stock | 92.35 | 6.24k | 156.85% |
| 2025-12-15 | Ms. Leslie V. NorwalkIndependent Director | -6.19k | 386.81k | Derivative Exercise and Sale | 84.95 - 155.09 | 6.24k | - |
| 2025-12-08 | Mr. Darin M. LippoldtChief Legal Officer & Corporate Secretary | -4.38k | 509.40k | Derivative Exercise and Sale | 43.24 - 159.65 | 43.41k | - |
| 2025-12-03 | Mr. Gary A. LyonsIndependent Director | -15.00k | 1.57M | Derivative Exercise and Sale | 47.89 - 152.61 | 120.48k | - |
| 2025-11-29 | Dr. Jude OnyiaChief Scientific Officer | 2.18k | 0.00 | Derivative Exercise and Retained Stock | - | 15.88k | 15.89% |
| 2025-11-29 | Dr. Jude OnyiaChief Scientific Officer | -2.25k | 342.06k | Derivative Exercise and Sale | 152.16 | 15.88k | - |
| 2025-11-25 | Mr. George J. MorrowIndependent Director | -15.00k | 1.43M | Derivative Exercise and Sale | 47.89 - 143.37 | 7.07k | - |
| 2025-11-05 | Dr. William H. RastetterIndependent Chairman of the Board | -18.00k | 1.87M | Derivative Exercise and Sale | 47.89 - 151.82 | 40.36k | - |
| 2025-11-01 | Mr. Kyle W. GanoPresident, CEO & Director | 313.00 | 0.00 | Derivative Exercise and Retained Stock | - | 140.41k | 0.22% |
| 2025-11-01 | Mr. Kyle W. GanoPresident, CEO & Director | -300.00 | 42.59k | Derivative Exercise and Sale | 141.97 | 140.41k | - |
| 2025-09-03 | Dr. Jude OnyiaChief Scientific Officer | -1.47k | 0.00 | Other Disposition | - | 13.70k | -9.69% |
| 2025-09-02 | Dr. Stephen A. SherwinIndependent Director | -1,000.00 | 0.00 | Other Disposition | - | 12.54k | -7.38% |
| 2025-08-07 | Dr. Kevin C. GormanDirector | -106.32k | 9.61M | Derivative Exercise and Sale | 35.99 - 126.41 | 514.60k | - |
| 2025-08-05 | Dr. Jude OnyiaChief Scientific Officer | -3.12k | 0.00 | Other Disposition | - | 15.17k | -17.04% |
| 2025-07-10 | Dr. Ingrid DelaetChief Regulatory Officer | -457.00 | 25.58k | Derivative Exercise and Sale | 79.02 - 135.00 | 4.73k | - |
| 2025-07-09 | Dr. Jude OnyiaChief Scientific Officer | -59.82k | 2.73M | Derivative Exercise and Sale | 84.74 - 130.46 | 18.29k | - |
| 2025-07-02 | Dr. Jude OnyiaChief Scientific Officer | -20.36k | 924.26k | Derivative Exercise and Sale | 84.74 - 130.13 | 18.29k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
